CELYAD ONCOLOGY Stock Was 30.85% Up Before The Weekend
(VIANEWS) – The Market ended the session with CELYAD ONCOLOGY (CYAD.BR) rising 30.85% to €0.98 on Friday while BEL 20 jumped 0.46% to €3,682.86. About CELYAD ONCOLOGY Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead…